Conditional survival in ovarian cancer: Results from the SEER dataset 1988-2001

Gynecologic Oncology

Volumn 109, Issue 2, 2008, Pages 203-209

  Choi, Mehee ^a   Fuller, Clifton D ^a   Thomas Jr , Charles R ^b   Wang, Samuel J ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Epidemiologic methods; Ovarian cancer; Prognosis; Survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CANCER GRADING; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CONDITIONAL SURVIVAL; DATA ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES;

AGED; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 42749091238     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.01.033     Document Type: Article

References (44)

1. American Cancer Society. Cancer Facts & Figures 2007 (2007), American Cancer Society, Atlanta
2. Henson D.E., and Gloeckler Ries L.A. On the estimation of survival. Semin Surg Oncol 10 (1994) 2-6
3. Gloeckler Ries L.A., Reichman M.E., Lewis D.R., Hankey B.F., and Edwards B.K. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 8 (2003) 541-552
4. Kato I., Severson R.K., and Schwartz A.G. Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data. Cancer 92 (2001) 2211-2219
5. Davis F.G., McCarthy B.J., Freels S., Kupelian V., and Bondy M.L. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer 85 (1999) 485-491
6. Hwang S.L., Yang Y.H., Lieu A.S., Chuang M.C., Chang S.J., Chang Y.Y., et al. The conditional survival statistics for survivors with primary supratentorial astrocytic tumors. J Neurooncol 50 (2000) 257-264
7. Lin C.L., Lieu A.S., Lee K.S., Yang Y.H., Kuo T.H., Hung M.H., et al. The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme. Surg Neurol 60 (2003) 402-406 discussion 406
8. Fuller C.D., Wang S.J., Thomas Jr. C.R., Hoffman H.T., Weber R.S., and Rosenthal D.I. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998. Cancer 109 (2007) 1331-1343
9. Henson D.E., Ries L.A., and Carriaga M.T. Conditional survival of 56,268 patients with breast cancer. Cancer 76 (1995) 237-242
10. Meng L., Maskarinec G., and Lee J. Ethnicity and conditional breast cancer survival in Hawaii. J Clin Epidemiol 50 (1997) 1289-1296
11. Christensen L.H., Engholm G., Ceberg J., Hein S., Perfekt R., Tange U.B., et al. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables? - A population-based study. Eur J Cancer 40 (2004) 1233-1243
12. Wang S.J., Luh J.Y., Fuller C.D., and Thomas C.R. Impact of ethnicity on conditional survival of breast cancer patients: analysis from the SEER database. 28th Annual San Antonio Breast Cancer Symposium (December 8, 2005, San Antonio, TX)
13. Wang S.J., Luh J.Y., Fuller C.D., and Thomas C.R. Geographic variation in conditional survival for breast cancer patients: a SEER database analysis. 29th Annual San Antonio Breast Cancer Symposium (December 8, 2006, San Antonio, TX)
14. Merrill R.M., Henson D.E., and Barnes M. Conditional survival among patients with carcinoma of the lung. Chest 116 (1999) 697-703
15. Skuladottir H., and Olsen J.H. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 21 (2003) 3035-3040
16. Wang S.J., Fuller C.D., and Thomas Jr. C.R. Ethnic disparities in conditional survival of patients with non-small cell lung cancer. J Thorac Oncol 2 (2007) 180-190
17. Fuller C.D., Wang S.J., Kachnic L., Wong A., and Thomas C.R. Conditional survival of gallbladder adenocarcinoma treated with radiotherapy: analysis from the SEER database. Int J Radiat Oncol Biol Phys 63 (2005) S274
18. Thomas C., Fuller C., Starling G., and Wang S. Conditional survival in gallbladder carcinoma: Results from the SEER 11 dataset. 2006 ASCO Annual Meeting Proceedings. J Clin Oncol vol. 24 (2006) 4130
19. Wang S.J., Emery R., Fuller C.D., Kim J.S., Sittig D.F., and Thomas C.R. Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer 10 (2007) 153-158
20. Merrill R.M., Henson D.E., and Ries L.A. Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum 41 (1998) 1097-1106
21. Wang S., Zamboni B., Wieand H., Yothers G., Dignam J., Raich P., et al. Conditional survival for patients with colon cancer: an analysis of National Surgical Adjuvant Breast and Bowel Project (NSABP) trials C-03 through C-06. 2006 ASCO Annual Meeting Proceedings. J Clin Oncol vol. 24 (2006) 6005
22. Wang S.J., Fuller C.D., Emery R., and Thomas C.R. Conditional survival in rectal cancer: a SEER database analysis. Gastrointest Cancer Res 1 (2007) 84-89
23. Luh J., Wang S., Fuller C., and Thomas C. A SEER database analysis of conditional survival for prostate cancer patients. 2006 ASCO Annual Meeting Proceedings. J Clin Oncol vol. 24 (2006) 14506
24. Klish D.S., Wang S.J., Kimler B.F., and Thomas C.R. Improved prognosis with time after diagnosis for patients with anal cancer. American Radium Society, 88th Annual Meeting, Wailea, HI (May 6, 2006)
25. Wang S.J., Fuller C.D., Luh J.Y., Thomas C.R., and Bleyer W.A. Older adolescents and young adults with cancer: conditional survival deficit. American Society for Therapeutic Radiology and Oncology, 48th Annual Meeting, Philadelphia, PA (November 5, 2006)
26. Kim E., Wang S.J., Fuller C.D., and Thomas Jr. C.R. Conditional survival for patients with thymic carcinoma from the SEER database. American Thoracic Society International Conference, San Francisco, CA (May 20, 2007)
27. *Stat Database: Incidence - SEER 13 Regs Public-Use, Nov 2004 Sub (1973-2002 varying). In: National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch, editor; released April 2006, based on the November 2005 submission.
28. *Stat software (www.seer.cancer.gov/seerstat) version 6.2.4. 2006.
29. Stambaugh M.D. Chapter 63. Ovary. In: Perez C., Brady L., Halperin E., and Schmidt-Ullrich R. (Eds). Principles and Practice of Radiation Oncology. 4th Edition (2004), Lippincott Williams & Wilkins, Philadelphia 1934-1957
30. Winter III W.E., Maxwell G.L., Tian C., Carlson J.W., Ozols R.F., Rose P.G., et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25 (2007) 3621-3627
31. Barnholtz-Sloan J.S., Tainsky M.A., Abrams J., Severson R.K., Qureshi F., Jacques S.M., et al. Ethnic differences in survival among women with ovarian carcinoma. Cancer 94 (2002) 1886-1893
32. Gill S., and Sargent D. End points for adjuvant therapy trials: has the time come to accept disease-free survival as a surrogate end point for overall survival?. Oncologist 11 (2006) 624-629
33. McGuire W.P., and Ozols R.F. Chemotherapy of advanced ovarian cancer. Semin Oncol 25 (1998) 340-348
34. Piccart M.J., Bertelsen K., James K., Cassidy J., Mangioni C., Simonsen E., et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst 92 (2000) 699-708
35. Aletti G.D., Gallenberg M.M., Cliby W.A., Jatoi A., and Hartmann L.C. Current management strategies for ovarian cancer. Mayo Clin Proc 82 (2007) 751-770
36. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 (2002) 1248-1259
37. Orlando M., Costanzo M.V., Chacon R.D., and Tajer C.D. Randomized trials of combination chemotherapy versus monotherapy in relapsed ovarian carcinoma: a meta-analysis of published data. ASCO Annual Meeting, Chicago, IL (June 5, 2007)
38. Hoel D.G., Ron E., Carter R., and Mabuchi K. Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst 85 (1993) 1063-1068
39. Ravdin P. Adjuvant! Online 2007. Available from: http://www.adjuvantonline.com. In; Accessed November 16, 2007.
40. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., Boolbol S.K., Fey J.V., Tan L.K., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 (2003) 1140-1151
41. Diblasio C.J., and Kattan M.W. Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology 62 Suppl 1 (2003) 9-18
42. Brennan M.F., Kattan M.W., Klimstra D., and Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240 (2004) 293-298
43. Wang S.J., Fuller C.D., Kim J.S., Sittig D.F., Thomas C.R., and Ravdin P.M. A prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol (2008) (accepted for publication)
44. Wang S.J., Fuller C.D., Sittig D.F., Holland J.M., and Thomas C.R. A regression model for predicting conditional survival for head & neck cancer patients: a SEER analysis. ASCO Annual Meeting, Chicago, IL (June 5, 2007)